Cure8 news brief
The paper links a Crohn’s disease GWAS signal to reduced LACC1 expression in lymphocytes and to altered immunometabolic function, clarifying a potential mechanism by which genetic variation contributes to IBD risk. It advances basic understanding of disease biology but does not report new treatments.
Researchers (IBD genetics, immunology, metabolism), clinicians interested in IBD pathogenesis, and informed patients following IBD research
This Nature article reports laboratory and human-genetics work linking common and rare LACC1 (C13ORF31/FAMIN) variants to altered LACC1 expression and immune/metabolic functions in lymphocytes and myeloid cells, with relevance to Crohn’s disease and other inflammatory bowel diseases.
The authors use population genetics (eQTL analyses), cellular assays, and experimental models to trace how a CD-associated noncoding variant reduces LACC1 expression in T cells and how coding variants can change protein function. They then examine downstream effects on cellular metabolism and immune responses that could plausibly influence colitis risk.
This is a mechanistic, laboratory-based study using human genetics and cellular/animal experiments. Findings clarify biology at a GWAS locus but are early-stage; they do not imply immediate clinical changes. Read the full paper for methods and limitations.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
The review brings together evidence that genetics, immune responses, the gut microbiome, and environmental triggers interact to cause Crohn's disease and ulcerative colitis.
The study explores whether larger spleen size might play a causal role in the risk of ulcerative colitis or Crohn’s disease, using genetic data to reduce confounding. If a causal link exists, spleen volume could be a...
Genetic ancestry can influence IBD risk and disease course, and most prior studies focused on European populations.
